Company Filing History:
Years Active: 2022-2025
Title: Chantal Mérette: Innovator in Electroretinography for Psychiatric Disorders
Introduction
Chantal Mérette is a distinguished inventor based in Canada, recognized for her contributions to the field of electroretinography (ERG) and its applications in psychiatric disorders. With a total of two patents to her name, she has made significant strides in understanding the relationship between ERG parameters and psychiatric conditions.
Latest Patents
Chantal's latest patents focus on the use of electroretinography for the assessment of psychiatric disorders. The methods described in her patents include diagnosis, prognosis, patient stratification, and prediction of pharmacological response in patients afflicted by psychiatric disorders based on ERG parameters. These innovative approaches aim to enhance the understanding and treatment of psychiatric conditions through advanced diagnostic techniques.
Career Highlights
Chantal Mérette is affiliated with Université Laval, where she continues to advance her research and innovation in the field. Her work has garnered attention for its potential to revolutionize the way psychiatric disorders are diagnosed and treated.
Collaborations
Chantal has collaborated with notable colleagues, including Marc Hébert and Michel Maziade, contributing to a rich environment of research and innovation.
Conclusion
Chantal Mérette's work in electroretinography represents a significant advancement in the assessment of psychiatric disorders. Her innovative patents and collaborations highlight her commitment to improving diagnostic methods in this critical field.